Premium
Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
Author(s) -
Lee Ji Yeon,
Vinayagamoorthy Nadimuthu,
Han Kyungdo,
Kwok Seung Ki,
Ju Ji Hyeon,
Park Kyung Su,
Jung SeungHyun,
Park SungWon,
Chung YeunJun,
Park SungHwan
Publication year - 2016
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.39402
Subject(s) - cyp2d6 , genotype , hydroxychloroquine , medicine , single nucleotide polymorphism , polymorphism (computer science) , gastroenterology , immunology , disease , biology , cytochrome p450 , genetics , metabolism , covid-19 , infectious disease (medical specialty) , gene
Objective To evaluate associations of genetic polymorphisms in cytochrome P450 (CYP) isoforms 2D6, 3A5, and 3A4 with blood concentrations of hydroxychloroquine (HCQ) and its metabolite, N ‐desethyl HCQ (DHCQ), in patients with systemic lupus erythematosus (SLE). Methods SLE patients taking HCQ for >3 months were recruited and were genotyped for 4 single‐nucleotide polymorphisms in CYP2D6*10, CYP3A5*3, and CYP3A4*18B. Blood HCQ and DHCQ concentrations ([HCQ] and [DHCQ]) were measured and their association with corresponding genotypes was investigated. Results A total of 194 patients were included in the analysis. CYP2D6*10 polymorphisms (rs1065852 and rs1135840) were significantly associated with the [DHCQ]:[HCQ] ratio after adjustment for age, sex, dose per weight per day, and SLE Disease Activity Index score ( P = 0.03 and P < 0.01, respectively). In adjusted models, the [DHCQ]:[HCQ] ratio was highest in patients with the G/G genotype of the CYP2D6*10 (rs1065852) polymorphism and lowest in those with the A/A genotype ( P = 0.03). Similarly, the [DHCQ]:[HCQ] ratio was highest in patients with the C/C genotype of the CYP2D6*10 (rs1135840) polymorphism and lowest in those with the G/G genotype ( P < 0.01). The CYP2D6*10 (rs1065852) polymorphism was significantly related to the [DHCQ] ( P = 0.01). However, the polymorphisms of CYP3A5*3 and CYP3A4*18B did not show any significant association with the [HCQ], [DHCQ], or [DHCQ]:[HCQ] ratio. Conclusion Our study showed that the [DHCQ]:[HCQ] ratio was related to CYP2D6 polymorphisms in Korean lupus patients taking oral HCQ. CYP polymorphisms may explain why there is wide variation in blood HCQ concentrations. The role of an individual's CYP polymorphisms should be considered when prescribing oral HCQ.